Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
Key facts
- Who runs it
- Universiti Putra Malaysia
- Where
- Malaysia4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 351 people, planned
- Started
- 13 Jan 2026
- Planned end
- Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Influenza and Tdap Vaccination Educational and Learning Module
- Record updated
- 1 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Pregnant women aged 18 years and older
- Before or equal to 32 weeks of gestation as we need to follow-up the patients again at 36 weeks of gestation before delivery occurs
- Able to understand and consent to participation in the study
Who cannot take part
- Pregnant women with severe anaphylactic or allergic reactions to previous dose of influenza or Tdap vaccination
- Non-Malaysian
This trial is currently available in Malaysia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The main questions it aims to answer are:
Read full original descriptionShow less
Does the InTroDuce-Programme increase knowledge and future intention of pregnant mothers to get vaccinated against Influenza and Tdap? How does demographic factors, attitudes and barriers affect vaccination decisions among pregnant mothers?
Researchers will compare InTroDuce-Programme to standard care (routine antenatal care) to see if InTroDuce-Programme works to improve knowledge and future intention of pregnant mothers to be vaccinated against Influenza and Tdap. Participants will:
Receive the web-based educational module (InTroDuce-Programme), which covers the importance, safety, and effectiveness of vaccinations, as well as addressing common concerns.
Be followed up one month after the intervention. Answer questionnaires before and after the intervention to measure changes in vaccination knowledge and future intention to get vaccinated
The 2 groups in the trial
- ControlNo study treatment, for comparison
Standard antenatal care
- InterventionTreatment being tested
Influenza and Tdap Vaccination Web-based Educational and Learning Module (InTroDuce-Programme)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of the Influenza and Tdap (Tetanus, Diphtheria, Acellular Pertussis) Vaccination Educational and Learning Module (InTroDuce-Programme) in Improving Knowledge and Future Uptake of Vaccination Among Pregnant Mothers in Primary Care Clinics: A Randomised Control Trial Secondary IDs
- Publications
- Record updated
- 1 May 2026